How it went
Did it last?
- 1 of 5 said the benefit wore off: the one who relapsed.
- 1 of 5 needed to keep doing it to stay well.
Read from what people wrote. A story that ends without a follow-up counts as lasting, so treat these as minimums.
| Outcome described | Accounts | Share |
|---|---|---|
| Full recovery | 0 | 0% |
| Near-full | 1 | 20% |
| Substantial | 1 | 20% |
| Partial | 1 | 20% |
| Relapsed | 1 | 20% |
| No benefit | 1 | 20% |
Only 5 accounts. Treat these percentages as anecdotes, not rates.
By how ill people were
| Severity at worst | How it went | n | Recovered |
|---|---|---|---|
| Moderate | 3 | 0% | |
| Severe | 1 | 100% |
1 accounts don’t say how ill the person was.
All 5 accounts
-
the best treatments I've found
Shanti1 credits this vasodilator/oxygen combination with improving brain circulation and says episodes of feeling oxygen-starved, once frequent, are now rare, describing sustained improvement "over time as underlying conditions addressed." No specific doses…
-
A Calcium Channel Blocker for ME/CFS and Fibromyalgia? Nimodipine Pt. II
Nimodipine, a dihydropyridine calcium channel blocker, caused a severe adverse reaction in this patient after just two tablets, one per day. Illness duration before the trial is not stated. She experienced paralysis in her arms and legs, which reversed only…
-
NIMODIPINE use in M.E. / CFS : A comprehensive guide. S. Parker (MBA, BSc) January 2014
Amlodipine, a dihydropyridine calcium channel blocker, was taken for about a month by this ME/CFS patient in Australia. Illness duration before starting is not stated. Her POTS-type symptoms had started improving by the one-month mark. The post is written…
-
NIMODIPINE use in M.E. / CFS : A comprehensive guide. S. Parker (MBA, BSc) January 2014
Nimodipine, a dihydropyridine calcium channel blocker, gave this ME/CFS patient a "noticeable cognitive benefit" at an unspecified dose. Illness duration before starting is not stated. In a later update to the same thread, posted in 2021, they reported that…
-
NIMODIPINE use in M.E. / CFS : A comprehensive guide. S. Parker (MBA, BSc) January 2014
Nimodipine, a dihydropyridine calcium channel blocker, was titrated from 15mg up to a maintenance dose of 90mg a day (30mg three times daily) over 7-plus years of treatment described in her own guide. She started at just 20-25% of normal functional capacity,…